Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

The WIN Consortium and New York University Cancer Institute Collaborate

Published: Tuesday, February 12, 2013
Last Updated: Tuesday, February 12, 2013
Bookmark and Share
The Worldwide Innovative Network (WIN) in personalized cancer medicine Consortium is proud to announce that New York University Cancer Institute has joined as a member of the Consortium.

This new partnership will ensure that NYU Cancer Institute play an active and vital role in WIN’s efforts to translate the most innovative approaches in personalized cancer medicine into patient care worldwide. NYU Cancer Institute is an NCI-designated Comprehensive Cancer Center for more than 33 years, a prestigious ranking conferred to select institutions characterized by scientific excellence, the capability to integrate a diversity of research approaches, and leadership in NCI-funded research efforts.

The WIN Consortium was created to spur collaboration between all stakeholders in personalized cancer medicine and to carry out cross-sector, worldwide clinical trials through the Consortium’s global network of academic and industry partners. With significant ongoing oncologic clinical trials, established multidisciplinary research structures, and a track record of successful research partnerships, NYU Cancer Institute is poised to play an integral role in the Consortium.

“NYU Cancer Institute joining WIN is an important step in the continued development of the Consortium’s capabilities and potential,” stated WIN Consortium Chairman Dr. John Mendelsohn. “The clear strengths NYU brings – experience serving a diverse patient population, excellence in disease-focused and basic science research, and committed, involved leadership – will help speed the translation of personalized cancer medicine innovations into the treatment of cancer patients.”

Dr. William Carroll, Director of the NYU Cancer Institute, noted, “This partnership will provide increased opportunities for the NYU Cancer Institute to play a strong role in innovative, global clinical trials and projects. We believe that this collaboration is strategically significant to advancing the practice of personalized cancer medicine and we look forward to active participation in the Consortium.”

Founded in 2010 on the recognition that greater success can be achieved through collaboration than any organization can achieve alone, the WIN Consortium is a global network of 29 leading academic, pharmaceutical, biotech, healthcare IT, and patient advocacy organizations working to accelerate the pace and reduce the cost of translating the most promising advances in genomic-based cancer research into the standard of patient care worldwide. WIN is a non-governmental, not-for-profit organization headquartered in Paris.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
A Diversity of Genomes
New DNA from understudied groups reveals modern genetic variation, ancient population shifts.
“Sixth Sense” May Be More Than Just A Feeling
The NIH Study shows that two young patients with a mutation in the PIEZ02 have problems with touch and proprioception, or body awareness.
Gene Could Reduce Female Mosquitoes
Virginia Tech researchers have found a gene that can reduce female mosquitoes over many generations.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Improving Crop Efficiency with CRISPR
New study of CRISPR-Cas9 technology from Virginia Tech shows potential to improve crop efficiency.
Fighting Cancer with Sticky Nanoparticles
Treatment that uses bioadhesive nanoparticles drug carriers proved more effective than conventional treatments for certain cancers.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Fighting Plant Pathogens with RNA
Researchers develop strategy that could lead to environmentally friendly fungicide to fight pathogens.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!